(CAH) Cardinal Health - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US14149Y1082

Pharmaceuticals, Medical Supplies, Surgical Products, Healthcare Products, Laboratory Products

CAH EPS (Earnings per Share)

EPS (Earnings per Share) of CAH over the last years for every Quarter: "2020-03": 1.19, "2020-06": 2.23, "2020-09": -0.86, "2020-12": 2.13, "2021-03": 0.4, "2021-06": 0.4, "2021-09": 0.94, "2021-12": 0.17, "2022-03": -5.05, "2022-06": 0.5, "2022-09": 0.4, "2022-12": -0.5, "2023-03": 1.34, "2023-06": -0.25, "2023-09": 0.02, "2023-12": 1.43, "2024-03": 1.05, "2024-06": 0.96, "2024-09": 1.7, "2024-12": 1.65, "2025-03": 2.1,

CAH Revenue

Revenue of CAH over the last years for every Quarter: 2020-03: 39157, 2020-06: 36689, 2020-09: 39065, 2020-12: 41541, 2021-03: 39275, 2021-06: 42586, 2021-09: 43968, 2021-12: 45457, 2022-03: 44836, 2022-06: 47103, 2022-09: 49603, 2022-12: 51469, 2023-03: 50487, 2023-06: 53453, 2023-09: 54763, 2023-12: 57445, 2024-03: 54911, 2024-06: 59867, 2024-09: 52277, 2024-12: 55264, 2025-03: 54878,

Description: CAH Cardinal Health

Cardinal Health Inc (NYSE:CAH) is a healthcare services and products company operating globally, providing customized solutions to various healthcare providers and patients. The companys diversified business model is reflected in its two main segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution.

Key Performance Indicators (KPIs) for Cardinal Health Inc include revenue growth, gross margin, and operating cash flow. With a market capitalization of approximately $39.4 billion, the companys financial health is crucial to its ability to invest in growth opportunities and return value to shareholders. The return on equity (RoE) of -50.14% indicates significant challenges in generating profits from shareholder equity, suggesting potential areas for improvement in operational efficiency or strategic direction.

The companys product and service offerings are broad, encompassing distribution of pharmaceuticals, medical supplies, and Cardinal Health branded products, as well as services like pharmacy management and supply chain solutions. This diversification can help mitigate risks associated with any single product or market. However, it also requires effective management across multiple business lines to maintain profitability.

From a valuation perspective, Cardinal Health Incs price-to-earnings (P/E) ratio of 25.85 and forward P/E of 17.51 suggest that the market expects earnings growth. The significant difference between the current and forward P/E ratios may indicate anticipated improvements in earnings. Analyzing these metrics in the context of industry peers and the broader healthcare sector can provide insights into whether CAH is undervalued or overvalued.

Cardinal Healths operational efficiency, ability to innovate, and capacity to manage its supply chain effectively will be critical in maintaining its competitive edge. The companys commitment to providing a wide range of healthcare products and services positions it as a significant player in the healthcare distribution and services market.

Additional Sources for CAH Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

CAH Stock Overview

Market Cap in USD 39,365m
Sector Healthcare
Industry Medical Distribution
GiC Sub-Industry Health Care Distributors
IPO / Inception 1987-12-31

CAH Stock Ratings

Growth Rating 97.0
Fundamental 38.6
Dividend Rating 45.6
Rel. Strength 88.2
Analysts 4.12 of 5
Fair Price Momentum 199.19 USD
Fair Price DCF 214.10 USD

CAH Dividends

Dividend Yield 12m 1.43%
Yield on Cost 5y 4.37%
Annual Growth 5y -4.84%
Payout Consistency 92.1%
Payout Ratio 25.4%

CAH Growth Ratios

Growth Correlation 3m 90.5%
Growth Correlation 12m 97.4%
Growth Correlation 5y 94.9%
CAGR 5y 27.97%
CAGR/Max DD 5y 1.13
Sharpe Ratio 12m 2.34
Alpha 61.09
Beta 0.349
Volatility 22.28%
Current Volume 1253.6k
Average Volume 20d 2145.3k
Stop Loss 154.7 (-3%)
What is the price of CAH shares?
As of July 18, 2025, the stock is trading at USD 159.46 with a total of 1,253,554 shares traded.
Over the past week, the price has changed by -1.67%, over one month by -3.01%, over three months by +18.73% and over the past year by +68.77%.
Is Cardinal Health a good stock to buy?
Partly, yes. Based on ValueRay´s Fundamental Analyses, Cardinal Health (NYSE:CAH) is currently (July 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 38.56 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CAH is around 199.19 USD . This means that CAH is currently undervalued and has a potential upside of +24.92% (Margin of Safety).
Is CAH a buy, sell or hold?
Cardinal Health has received a consensus analysts rating of 4.12. Therefore, it is recommended to buy CAH.
  • Strong Buy: 9
  • Buy: 2
  • Hold: 5
  • Sell: 1
  • Strong Sell: 0
What are the forecasts for CAH share price target?
According to our own proprietary Forecast Model, CAH Cardinal Health will be worth about 216.5 in July 2026. The stock is currently trading at 159.46. This means that the stock has a potential upside of +35.76%.
Issuer Target Up/Down from current
Wallstreet Target Price 172.2 8%
Analysts Target Price 155.5 -2.5%
ValueRay Target Price 216.5 35.8%